A major review details how AI enhances early detection and recurrence prediction in breast cancer imaging.
Key Details
- 1Systematic review covers research from 2006–2025 on AI in breast cancer imaging.
- 2AI-assisted mammography detects 29% more cancers compared to conventional reading without increasing false positives.
- 3AI reduces mammography reading time by ~40%, increasing radiologist efficiency.
- 4AI in 3D digital breast tomosynthesis finds 1.6 more cancers per 1,000 screens and reduces recall rate by 2.2%.
- 5AI in MRI identified imaging features up to one year pre-diagnosis and localized future cancer in 57% of cases.
- 6AI models also improve ultrasound interpretation consistency and biopsy analysis for recurrence risk.
Why It Matters
The review synthesizes evidence showing that AI not only boosts diagnostic accuracy and efficiency across imaging modalities, but also supports risk prediction and precision medicine. This highlights the growing value of AI as a clinical decision-support tool in breast imaging and underscores the challenges ahead for broad, equitable clinical adoption.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Analysis Predicts Immunotherapy Response in Rare Tumors
AI-based analysis of tumor pathology slides can predict immunotherapy outcomes in rare cancers, according to a recent MD Anderson study.
•EurekAlert
Framework Guides Digital Pathology and AI Integration for Labs
A new lifecycle framework outlines practical steps for sustainable digital pathology and AI program implementation in clinical labs.
•EurekAlert
Recent AI Advances in Digital Breast Pathology: Models, Explainability, and Applications
AI is rapidly transforming breast pathology by improving diagnostic accuracy, workflow efficiency, and precision medicine through advances in deep learning and multimodal models.